Business
Notice of Preliminary Results and Webcast
Notice of Preliminary Results and Webcast.
About this update from Cellbxhealth Plc
[{"type":"text","content":"\n \n \n \n \n \n \n \n For immediate release\n \n \n \n \n \n \n 03 April 2023\n \n \n \n \n \n \n \n \n \n \n \n \n \n ANGLE plc (\"the Company\")\n \n \n \n \n \n \n \n \n \n Notice of Preliminary Results and Webcast\n \n \n \n \n \n \n ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, will be releasing its preliminary results for the year ended 31 December 2022 on Friday 21 April 2023.\n \n \n \n \n \n A virtual meeting and webcast for analysts will be held at 10:00 am BST on Friday 21 April 2023. If you wish to attend, please register in advance and log on to the webcast approximately 5 minutes before 10:00 am on the day of the results. Details of how to attend can be accessed via ANGLE's Investor Centre page,\n \n \n https://angleplc.com/investor-relations/corporate-presentations/\n \n \n . Q&A time is reserved for analysts and a recording of the webcast will be made available on ANGLE's website following the results meeting.\n \n \n \n \n \n \n \n \n \n \n \n For further information:\n \n \n \n \n \n \n \n \n \n \n \n \n \n ANGLE plc\n \n \n \n \n \n \n +44 (0) 1483 343434\n \n \n \n \n \n \n \n Andrew Newland, Chief Executive\n \n \n Ian Griffiths, Finance Director\n \n \n Andrew Holder, Head of Investor Relations\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Berenberg (NOMAD and Joint Broker)\n \n \n \n Toby Flaux, Ciaran Walsh, Milo Bonser\n \n \n \n \n \n \n \n \n \n \n +44 (0) 20 3207 7800\n \n \n \n \n \n \n \n \n \n \n \n \n \n Jefferies (Joint Broker)\n \n \n \n Thomas Bective, Shaam Vora\n \n \n \n \n \n \n \n \n \n \n +44 (0) 20 7029 8000\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n FTI Consulting\n \n \n \n Simon Conway, Ciara Martin\n \n \n Matthew Ventimiglia (US)\n \n \n \n \n \n \n \n \n \n \n \n \n \n +44 (0) 203 727 1000\n \n \n \n \n +1 (212) 850 5624\n \n \n \n \n \n \n \n \n \n \n \n \n For Frequently Used Terms, please see the Company's website on\n \n \n https://angleplc.com/investor-relations/glossary/\n \n \n \n \n \n \n \n \n Notes for editors\n \n \n \n \n \n \n \n About ANGLE plc\n \n \n \n www.angleplc.com\n \n \n \n \n \n ANGLE is a world leading liquid biopsy company with sample-to-answe...